StockNews.com Initiates Coverage on Senseonics (NYSE:SENS)

StockNews.com assumed coverage on shares of Senseonics (NYSE:SENS) in a report issued on Thursday morning. The firm issued a sell rating on the stock.

Separately, HC Wainwright restated a “buy” rating and issued a $2.00 target price on shares of Senseonics in a research note on Wednesday, August 14th.

Senseonics Trading Up 0.4 %

NYSE:SENS opened at $0.34 on Thursday. The company has a market cap of $181.93 million, a PE ratio of -2.61 and a beta of 0.79. The business’s 50 day moving average is $0.36 and its two-hundred day moving average is $0.40. The company has a quick ratio of 2.89, a current ratio of 3.11 and a debt-to-equity ratio of 59.17. Senseonics has a 52 week low of $0.32 and a 52 week high of $0.75.

Senseonics (NYSE:SENS) last issued its earnings results on Thursday, August 8th. The company reported ($0.03) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.03). Senseonics had a negative net margin of 335.15% and a negative return on equity of 299.69%. The company had revenue of $4.87 million for the quarter, compared to analysts’ expectations of $4.86 million. On average, analysts predict that Senseonics will post -0.13 EPS for the current year.

Institutional Trading of Senseonics

A number of large investors have recently modified their holdings of the company. Price T Rowe Associates Inc. MD increased its position in Senseonics by 16.1% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 367,200 shares of the company’s stock valued at $196,000 after acquiring an additional 51,000 shares during the period. Cubist Systematic Strategies LLC increased its holdings in shares of Senseonics by 25.9% during the second quarter. Cubist Systematic Strategies LLC now owns 415,404 shares of the company’s stock valued at $166,000 after purchasing an additional 85,501 shares during the period. Vanguard Group Inc. raised its stake in shares of Senseonics by 0.7% during the first quarter. Vanguard Group Inc. now owns 22,525,039 shares of the company’s stock valued at $11,963,000 after purchasing an additional 155,715 shares in the last quarter. State Board of Administration of Florida Retirement System acquired a new stake in Senseonics in the first quarter worth about $91,000. Finally, Mirae Asset Global Investments Co. Ltd. grew its position in Senseonics by 30.2% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 909,931 shares of the company’s stock valued at $483,000 after buying an additional 211,128 shares in the last quarter. Institutional investors and hedge funds own 12.36% of the company’s stock.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.